About Emyria
Emyria is a company based in Perth (Australia) founded in 2018 by Adam James. Emyria has completed 1 acquisition, including Pax Centre. Emyria offers products and services including Investor Hub and ASX Announcements. Emyria operates in a competitive market with competitors including Q Bio, Briya, Medchart, Seqster and EMIS Health, among others.
- Headquarter Perth, Australia
- Founders Adam James
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Emyria Limited
-
Annual Revenue
$865.6 K (USD)-40.56as on Jun 30, 2025
-
Net Profit
-$2.07 M (USD)72.57as on Jun 30, 2025
-
EBITDA
-$2.77 M (USD)32.48as on Jun 30, 2025
-
Latest Funding Round
$5 M (USD), Post-IPO
Nov 22, 2021
-
Investors
Tattarang
& 3 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Emyria
Emyria is a publicly listed company on the ASX with ticker symbol EMD in Australia, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Emyria
Emyria offers a comprehensive portfolio of products and services, including Investor Hub and ASX Announcements.
Platform for accessing announcements and updates
Service providing corporate updates for investors
People of Emyria
Unlock access to complete
Unlock access to complete
Funding Insights of Emyria
Investors in Emyria
Emyria has secured backing from 4 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Tattarang, WA Health and Sixty-Two Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tattarang is engaged in private investments across multiple sectors.
|
Locked | Locked | Locked | |
|
WA Health is tasked with improving health services in Western Australia.
|
Locked | Locked | Locked | |
|
Corporate advisory and investment solutions are provided by Sixty-Two Capital.
|
Locked | Locked | Locked |
Investor details for Emyria
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Emyria
Emyria has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Pax Centre.
Investment portfolio details for Emyria
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Mental rehabilitation services are provided in Australia.
|
Locked | Locked | 0 | Locked |
Complete acquisition details for Emyria
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Emyria
Detailed financials for Emyria
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Emyria Comparisons
Peer comparison for Emyria
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Emyria
Emyria operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Q Bio, Briya, Medchart, Seqster and EMIS Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of clinical data management and analytics platform
|
|
| Locked | Locked | Locked |
Cloud-based tools for medical data collaboration and management are provided.
|
|
| Locked | Locked | Locked |
Cloud-based medical interoperability platform is provided for healthcare organizations.
|
|
| Locked | Locked | Locked |
Online platform for managing and storing health records
|
|
| Locked | Locked | Locked |
Interoperability solutions for healthcare organisations are provided by EMIS Health.
|
Detailed competitors of Emyria
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Emyria
Complete news archive for Emyria
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Emyria
Emyria was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Emyria is headquartered in Perth, Australia. It is registered at Perth, Western Australia, Australia.
Annual revenue of Emyria is $865.6K as on Jun 30, 2025.
Provider of therapy and care planning solutions using interoperable clinical data. The platform allows collaborating and integrating the patient-centered clinical data and evidence for real-time decision-making in care therapy. The network of clinicians, patients, researchers, and innovators can use medical knowledge from the resources, Emyria Data is the product for testing and validating novel treatment using patient data. Emyria Care is for improving patient care and Emyria Tech is for providing remote patient care and monitoring.
Emyria offers Investor Hub and ASX Announcements.
Yes, Emyria is publicly traded on ASX under the ticker symbol EMD.
Emyria has made 1 acquisition, including Pax Centre.
Emyria has 4 investors. Key investors include Tattarang, WA Health, Sixty-Two Capital, and Craig Darby.
The ticker symbol of Emyria is EMD on ASX.